Drug
Basal Bolus
Basal Bolus is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
75%(3 trials)
Phase Distribution
Ph phase_4
4
100%
Phase Distribution
0
Early Stage
0
Mid Stage
4
Late Stage
Phase Distribution4 total trials
Phase 4Post-market surveillance
4(100.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 44 (100.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_4
Durability of Combination of Insulin and GLP-1 Receptor Agonist or SGLT-2 Inhibitors Versus Basal Bolus Insulin Regimen in Type 2 Diabetes (BEYOND)
NCT04196231
completedphase_4
Linagliptin Inpatient Trial
NCT02004366
completedphase_4
Basal Bolus Versus Basal Insulin in Type 2 Diabetes Mellitus (T2DM)
NCT00979628
completedphase_4
Sitagliptin Therapy in Hospitalized Patients With Type 2 Diabetes
NCT01845831
Clinical Trials (4)
Showing 4 of 4 trials
NCT04196231Phase 4
Durability of Combination of Insulin and GLP-1 Receptor Agonist or SGLT-2 Inhibitors Versus Basal Bolus Insulin Regimen in Type 2 Diabetes (BEYOND)
NCT02004366Phase 4
Linagliptin Inpatient Trial
NCT00979628Phase 4
Basal Bolus Versus Basal Insulin in Type 2 Diabetes Mellitus (T2DM)
NCT01845831Phase 4
Sitagliptin Therapy in Hospitalized Patients With Type 2 Diabetes
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4